Mytrelle at Meeting on the Mesa
Myrtelle Announces Presentation of Encouraging Interim Results from its Phase 1/2 Gene Therapy Trial for Canavan Disease at the 2025 Cell & Gene Meeting on the Mesa
Article Date
October 6, 2025
This article is featured on another website.
Go to article
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 12, 2026
Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies
January 26, 2026
Leveraging China to Maximize Global Study Impact
China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…
January 26, 2026
Leveraging China to Maximize Global Study Impact
China's healthcare market is expanding rapidly due to urbanization, with a population of about 1.4…